JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2013, Vol. 51 ›› Issue (11): 85-89.

• Articles • Previous Articles     Next Articles

Expression of microRNA-150 in colorectal carcinoma and its clinical significance

FAN Zhi-bin1, YU Wei-fang2,  ZHANG Li-jing1, LIU Bo1, WU Chen-peng3,ZHANG Xue-ming4, ZHAO Zeng-ren1   

  1. 1. Department of General Surgery, The First Hospital of Hebei Medical University, Shijiazhuang 050031, China;
    2. Department of Endoscopy Center, The First Hospital of Hebei Medical University, Shijiazhuang 050031, China;
    3. Department of Pathology, Tangshan Gongren Hospital, Tangshan 063000, Hebei, China;
    4. Department of Anorectum Section, Tangshan Gongren Hospital, Tangshan 063000, Hebei, China
  • Received:2012-08-21 Online:2013-11-10 Published:2013-11-10

Abstract:

Objective  To study the expression of microRNA-150(miR-150) in colon cancer cell lines and colorectal cancer (CRC) tissues, and evaluate its clinicopathological significance. Methods  miR-150 was examined in eight colon cancer cell lines, 45 CRC tissues and their matched normal tissues by real-time quantitative reverse transcription PCR (qRT-PCR). The relationships between miR-150 and clinicopathological information were analyzed. Results  Expression of miR-150 in eight colon cancer cell lines was lower than normal tissues. Moreover, miR-150 expression in tumor tissues was much lower than their matched normal tissues (P<0.05). Low miR-150 level was strongly associated with the differentiated degree (P<0.05) and pathological type (P<0.01). Conclusion  miR-150 is down-regulated not only in colon cancer cell lines but in tumor tissues, and its low expression is associated with the differentiation and pathological type. miR-150 might play a role in the course of CRC diagnosis and treatment.

Key words: microRNA-150; Colorectal cancer; Real-time quantitative reverse transcription PCR; Mucinous cancer

CLC Number: 

  • R735.1
[1] LIU Ying, LI Ke, XU Shu-ning, LIU Wen-jing, HOU Xin-fang, WANG Ju-feng. Relationships between SphK1 and esophageal cancer
invasion and metastasis
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 21-.
[2] LI Qiang, YANG Zhe, ZHAO Ying, HAN Jun-qing. A preliminary study toward validating EGFR expression in esophageal
carcinoma as used to predict the sensitivity to chemoradiotherapy
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 96-.
[3] ZHANG Zhen-wei1, JIANG Zhong-min2. Expression and clinical significance of Mel-18 mRNA in
esophageal squamous cell carcinoma
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 78-.
[4] JIA Hui1,2, YU Jin-ming2, SONG Ping-ping3, ZHANG Wei-di3, MU Dian-bin4, HAN Da-li2, ZHANG Xi-qin2. Expression of Ki-67 and pathomorphological response after preoperative  chemoradiotherapy in patients with esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 125-.
[5] HAO Xiao-rui, LU Xue-feng, SUN Na, LIU Sheng-nan, LIU Liang. Expression of decoy receptor 3 in esophageal squamous cell carcinoma and  its correlation with tumor infiltrating T lymphocytes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 134-.
[6] ZHANG Hao1,ZHOU Ying-Zhi2, DIAO YuTao3, LI Hui-Qing3, ZHOU Rui-xue4, ZHAO De-li4, LEI Fu-hua4. A  case-control study on influencing factors of esophageal squamous cellcancer in males of Feicheng City [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(11): 102-105.
[7] SUN Xiaohong, PANG Zuoliang, LUO Dongbo. Expressions of MMP-7 and MMP-2 in esophageal cancer patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(7): 102-104.
[8] TIAN Guangliang1, QIU Chen1, WANG Junchao2, HAO Chengcheng3, WANG Jiao1, LIU Huizhong1. Relationship between tumor regression speed and prognosis of  radiation therapy in esophageal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(2): 136-139.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!